Sign in

CIK 0001674632

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Beta Bionics, Inc.

Sign in to watch
Ticker
BBNX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475386878
Phone
+1 949-427-7785
Business address
11 HUGHES, IRVINE, CA, 92618
Former names
Beta Bionics, Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,285,734
in 20 filings, $2.5M under 10b5-1 plans

Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Feider Stephen Chief Financial Officer Option exercise 10b5-1 +8,874 $5.10 $45K 168,252
2026-11-11 Feider Stephen Chief Financial Officer Sale 10b5-1 −8,874 $17.21 $153K 159,378
2026-11-11 Feider Stephen Chief Financial Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −8,874 29,695
2026-11-09 Feider Stephen Chief Financial Officer Option exercise 10b5-1 +744 $5.10 $4K 160,122
2026-11-09 Feider Stephen Chief Financial Officer Sale 10b5-1 −744 $17.00 $13K 159,378
2026-11-09 Feider Stephen Chief Financial Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −744 38,569
2026-11-05 Feider Stephen Chief Financial Officer Option exercise 10b5-1 +382 $5.10 $2K 159,760
2026-11-05 Feider Stephen Chief Financial Officer Sale 10b5-1 −382 $17.04 $7K 159,378
2026-11-05 Feider Stephen Chief Financial Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −382 39,313
2026-11-02 Hopman Mark Chief Commercial Officer Sale 10b5-1 −370 $16.90 $6K 54,143
2026-10-27 Mensinger Mike Chief Product Officer Sale 10b5-1 −2,650 $22.00 $58K 174,740
2026-10-26 Hopman Mark Chief Commercial Officer Sale 10b5-1 −821 $20.00 $16K 54,513
2026-10-14 Hopman Mark Chief Commercial Officer Sale −775 $17.35 $13K 55,334
2026-10-01 Hopman Mark Chief Commercial Officer Sale −370 $18.96 $7K 56,109
2026-09-22 Jones Christy Director Sale 10b5-1 −6,430 $23.00 $148K 19,564
2026-09-16 Mensinger Mike Chief Product Officer Sale 10b5-1 −2,650 $22.00 $58K 177,390
2026-09-16 Hopman Mark Chief Commercial Officer Sale 10b5-1 −30,779 $20.13 $620K 56,479
2026-09-14 Hopman Mark Chief Commercial Officer Sale 10b5-1 −775 $15.52 $12K 86,382
2026-09-09 Hopman Mark Chief Commercial Officer Sale 10b5-1 −35,994 $18.46 $665K 88,033
2026-09-09 Hopman Mark Chief Commercial Officer Sale 10b5-1 −36,870 $18.46 $681K 87,157

Page 1 of 11 · 210 trades